AAAAAA
Results:
1-18
|
Results: 18
Authors:
Silver, H
Citation: H. Silver, Cyril Taylor - Obituary, BR MED J, 322(7289), 2001, pp. 801-801
Authors:
Silver, H
Shlomo, M
Citation: H. Silver et M. Shlomo, Perception of facial emotions in chronic schizophrenia does not correlate with negative symptoms but correlates with cognitive and motor dysfunction, SCHIZOPHR R, 52(3), 2001, pp. 265-273
Authors:
Lee, T
Silver, H
Citation: T. Lee et H. Silver, Etiology and epidemiology of preterm premature rupture of the membranes, CLIN PERIN, 28(4), 2001, pp. 721
Authors:
Silver, H
Citation: H. Silver, Economic conditions and welfare reform, RELAT IND, 56(3), 2001, pp. 625-628
Authors:
Silver, H
Youdim, MBH
Citation: H. Silver et Mbh. Youdim, MAO-A and MAO-B activities in rat striatum, frontal cortex and liver are unaltered after long-term treatment with fluvoxamine and desipramine, EUR NEUROPS, 10(2), 2000, pp. 125-128
Authors:
Schwartz, M
Silver, H
Citation: M. Schwartz et H. Silver, Lymphocytes, autoantibodies and psychosis - Coincidence versus etiologicalfactor: An update, ISR J PSYCH, 37(1), 2000, pp. 32-36
Authors:
Silver, H
Citation: H. Silver, Vitamin B12 levels are low in hospitalized psychiatric patients, ISR J PSYCH, 37(1), 2000, pp. 41-45
Authors:
Silver, H
Citation: H. Silver, The public realm: exploring the city's quintessential social territory., INT J URBAN, 24(2), 2000, pp. 493-496
Authors:
Silver, H
Citation: H. Silver, Reconstructing Chinatown: ethnic enclave, global change., INT J URBAN, 24(2), 2000, pp. 493-496
Authors:
Silver, H
Aharon, N
Schwartz, M
Citation: H. Silver et al., Attention deficit-hyperactivity disorder may be a risk factor for treatment-emergent tardive dyskinesia induced by risperidone, J CL PSYCH, 20(1), 2000, pp. 112-114
Authors:
Silver, H
Barash, I
Aharon, N
Kaplan, A
Poyurovsky, M
Citation: H. Silver et al., Fluvoxamine augmentation of antipsychotics improves negative symptoms in psychotic chronic schizophrenic patients: a placebo-controlled study, INT CLIN PS, 15(5), 2000, pp. 257-261
Authors:
Thurer, RL
Luban, NLC
AuBuchon, JP
Silver, H
McCarthy, LJ
Dzik, S
Stowell, CP
Moore, SB
Vamvakas, EC
Armstrong, W
Kanter, MH
Jeter, E
Becker, J
Higgins, M
Galel, S
Kleinman, S
Marshall, CS
Newman, R
Ocariz, JA
Blackall, D
Petz, LD
Toy, P
Oberman, H
Siegel, DL
Price, TH
Slichter, SJ
Gernsheimer, T
Mintz, P
Goodnough, LT
Lipford, EH
Simpson, MB
Citation: Rl. Thurer et al., Universal WBC reduction, TRANSFUSION, 40(6), 2000, pp. 751-752
Authors:
Perkins, J
Kaminer, L
Kruskall, M
Cannon, M
Uhl, L
Dzik, W
Silver, H
O'Neill, M
Popovsky, M
King, K
Ness, P
AuBuchon, J
Shapiro, A
Yomtovian, R
Petz, LD
Citation: J. Perkins et al., Should the FDA mandate that autologous units drawn and transfused within asingle institution be tested for markers of infectious disease?, TRANSFUSION, 40(6), 2000, pp. 752-754
Authors:
Tsongalis, GJ
Wu, AHB
Silver, H
Ricci, A
Citation: Gj. Tsongalis et al., Applications of forensic identity testing in the clinical laboratory, AM J CLIN P, 112(1), 1999, pp. S93-S103
Authors:
Hannan, A
English, S
Silver, H
Citation: A. Hannan et al., Why innovate? Some preliminary findings from a research project on 'innovations in teaching and learning in higher education', STUD HIGH E, 24(3), 1999, pp. 279-289
Authors:
Silver, H
Aharon, N
Hausfater, N
Jahjah, N
Citation: H. Silver et al., The effect of augmentation with moclobemide on symptoms of schizophrenia, INT CLIN PS, 14(3), 1999, pp. 193-195
Authors:
Strong, R
Silver, H
Perini, M
Citation: R. Strong et al., Keeping it simple and deep, EDUC LEADER, 56(6), 1999, pp. 22-24
Authors:
Silver, H
Citation: H. Silver, Managing to innovate in higher education, BR J EDUC S, 47(2), 1999, pp. 145-156
Risultati:
1-18
|